KEQU · NASDAQ · Furnishings, Fixtures & Appliances

Kewaunee Scientific (KEQU)

Designs, manufactures, and installs laboratory furniture, infrastructure, and biosafety equipment.

$34.05
vs last close−0.62 (−1.79%)
Loading prices…

Kewaunee Scientific CorporationKEQU
Consumer Discretionary

It sells laboratory furniture and infrastructure through Lab Products Group and International operations. NuAire adds biosafety cabinets, incubators, and ultralow freezers to the product range.

Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The Lab Products Group supplies cabinetry, fume hoods, flexible systems, worksurfaces, workstations, and related products, including NuAire biological-safety cabinets, CO2 incubators, and ultralow freezers. Its systems serve laboratory settings requiring coordinated furniture, airflow, and specialized equipment.

International covers non-US operations. Manufacturing is based in Statesville, North Carolina, and Bangalore, India, while sales offices span the United States, India, Saudi Arabia, and Singapore. NuAire broadened the product range, and its distribution partners extend the company's reach beyond the US.

Company facts

CEOThomas D. Hull III
ListedFeb 14, 1968
ExchangeNASDAQ
HeadquartersStatesville, NC
CountryUnited States
Employees1,231
CIK0000055529
ISINUS4928541048

Market cap$99.5M
EPS (ttm)$2.76
P/E (ttm)12.56
ROE11.3%
P/B1.33
P/S0.3588
Dividend yieldDiv yield
Beta0.70vs XLY 0.21

No analyst consensus on record.

Next report
Dec 16, 26
estimated · in 85 days
EPS estimate
Revenue estimate
Fiscal quarter
Q2 FY27

EPSReportedEstimate

Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26Dec '26
Reported$1.09$1.95$1.10$0.91$0.28$1.14$0.58Pending
Estimate
Surprise

RevenueReportedEstimate

Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26Dec '26
Reported$67.2M$77.1M$71.1M$70.1M$69.4M$71.4M$66.3MPending
Estimate
Surprise
Estimate
ReportedDue Dec 16, 2026
Estimate
ReportedDue Dec 16, 2026
View details

Debt to equity74.00%
Current ratio220.10%

ProfitabilityRevenueNet incomeNet margin

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue$47.8M$67.2M$77.1M$71.1M$70.1M$69.4M$71.4M$66.3M
Net income$3.0M$1.4M$4.9M$3.1M$2.4M$692.0K$3.4M$1.7M
Net margin6.3%2.0%6.3%4.3%3.5%1.0%4.7%2.6%

GrowthOperating income

Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Operating income$4.4M$2.3M$8.5M$4.8M$4.1M$2.6M$5.2M$3.2M
YoY growth−13.2%−40.9%+52.9%+86.8%−7.4%+14.8%−38.6%−34.3%

Balance sheet, Jul 31, 2026Cash & short-term investments $8.2M · Total debt $55.5M · Total assets $175.8M · Shareholders' equity $75.0M

Revenue
$66.3M
Operating income
$3.2M
Net income
$1.7M
View details

No dividends on record.

Institutions41.41%1.20M shares
32 holders · as of Jun 30, 2026
Insiders19.26%557.6K shares
12 holders · as of Jul 2, 2026
Strategic holders6.21%179.8K shares
1 holder · as of Oct 30, 2019
Other33.12%959.1K shares
remainder

2.90M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Northern Trust CorpInstitution
8.22%238,111as of Jun 30, 2026
Zucker Anita GInsider
6.70%193,876filed Feb 5, 2025
6 Marital TrustStrategic
6.21%179,790filed Oct 30, 2019
Dimensional Fund Advisors LPInstitution
6.05%175,042as of Jun 30, 2026
Minerva Advisors LLCInstitution
5.16%149,410as of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jan 7, 2026Thomas David Iii Hulldirector, officer: President, CEO−2,177$37.50
Jan 6, 2026Donald T. III Gardnerofficer: Chief Financial Officer−2,000$37.57
Dec 31, 2025Thomas David Iii Hulldirector, officer: President, CEO−629$37.66
Dec 30, 2025Thomas David Iii Hulldirector, officer: President, CEO−29$38.00
Dec 29, 2025Thomas David Iii Hulldirector, officer: President, CEO−884$38.01
View details

Compare

CompanyPriceChange
Kewaunee Scientific$34.05−1.79%$99.5M12.60.4−6.7%
Thermo Fisher Scientific$657.56−0.18%$244.81B35.425.15.3+10.5%
Median35.425.15.3+10.5%